Axogen outlines at least $270M 2026 revenue on at least 20% growth amid Avance biologic channel transition
Axogen, Inc. Common Stock · ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS · Now $38.72
+3.4% in 7d after detection
Post-detection moves
1h
—
1d
-0.5%
3d
+3.1%
7d
+3.4%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS